{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:05:44Z","timestamp":1776427544880,"version":"3.51.2"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bpa.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T03:07:18Z","timestamp":1595387238000},"page":"651-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacogenomics, concepts for the future of perioperative medicine and pain management: A review"],"prefix":"10.1016","volume":"34","author":[{"given":"Alan D.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody M.","family":"Koress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew B.","family":"Novitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Urits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan S.","family":"Renschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward S.","family":"Alpaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bpa.2020.07.004_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03602530902843483","article-title":"Polymorphism of human cytochrome P450 enzymes and its clinical impact","volume":"41","author":"Zhou","year":"2009","journal-title":"Drug Metab Rev"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1526-4637.2012.01296.x","article-title":"CYP2D6 poor metabolizer genotype and smoking predict severe postoperative pain in female patients on arrival to the recovery room","volume":"13","author":"Yang","year":"2012","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00000542-200503000-00028","article-title":"Pharmacogenetics of anesthetic and analgesic agents","volume":"102","author":"Palmer","year":"2005","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.bpa.2020.07.004_bib4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.clinthera.2014.06.016","article-title":"Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting","volume":"36","author":"He","year":"2014","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.004_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/tpj.2014.56","article-title":"Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics","volume":"15","author":"Sadhasivam","year":"2015","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/pr.56.1.2","article-title":"Autonomic nervous system pharmacogenomics: a progress report","volume":"56","author":"Kirstein","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2008.02.023","article-title":"Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women","volume":"139","author":"Landau","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/ANE.0000000000000563","article-title":"COMT gene haplotypes are closely associated with postoperative fentanyl dose in patients","volume":"120","author":"Zhang","year":"2015","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00228-011-1093-5","article-title":"Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study","volume":"68","author":"Andreassen","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.07.004_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jcph.405","article-title":"Role of SLCO1B1, ABCB1, and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients","volume":"55","author":"Mei","year":"2015","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.004_bib27","first-page":"153","article-title":"Genetics and implications in perioperative analgesia","volume":"28","author":"Trescot","year":"2014","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/ACO.0b013e3283556129","article-title":"Pharmacogenetics in perioperative medicine","volume":"25","author":"Cohen","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.bpa.2020.07.004_bib29","series-title":"Anesthesiology","author":"American Society of Anesthesiologists","year":"2005"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1399-0004.2001.590306.x","article-title":"Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia","volume":"59","author":"Stewart","year":"2001","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/humu.1203","article-title":"Genotype-phenotype comparison of the Swiss malignant hyperthermia population","volume":"18","author":"Girard","year":"2001","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.004_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/humu.10098","article-title":"RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in\u00a0vitro contracture test phenotypes","volume":"20","author":"Robinson","year":"2002","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archneur.61.1.106","article-title":"Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in\u00a0vitro contracture tests, and genetic characterization","volume":"61","author":"Guis","year":"2004","journal-title":"Arch Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.bpa.2020.07.004_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(97)80492-8","article-title":"Genetic predisposition to drug-induced hepatotoxicity","volume":"26","author":"Larrey","year":"1997","journal-title":"J\u00a0Hepatol"},{"issue":"1\u20132","key":"10.1016\/j.bpa.2020.07.004_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-2797(98)00081-7","article-title":"Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis","volume":"116","author":"Eliasson","year":"1998","journal-title":"Chem Biol Interact"},{"issue":"9012","key":"10.1016\/j.bpa.2020.07.004_bib36","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(96)91011-9","article-title":"Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis","volume":"347","author":"Kharasch","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bpa.2020.07.004_bib37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/bja\/aeg103","article-title":"Do genes influence outcome from anaesthesia?","volume":"90","author":"Sweeney","year":"2003","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.004_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00000542-200408000-00006","article-title":"Anesthetic requirement is increased in redheads","volume":"101","author":"Liem","year":"2004","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1533-2500.2007.00153.x","article-title":"Complicated pain management in a CYP450 2D6 poor metabolizer","volume":"7","author":"Foster","year":"2007","journal-title":"Pain Pract"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.004_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.anclin.2017.01.015","article-title":"Pharmacogenomics in pain management","volume":"35","author":"Saba","year":"2017","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.bpa.2020.07.004_bib41","first-page":"49","article-title":"The pharmacogenomics of pain management: prospects for personalized medicine","volume":"9","author":"Ting","year":"2016","journal-title":"J\u00a0Pain Res"},{"issue":"13\u201314","key":"10.1016\/j.bpa.2020.07.004_bib42","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.clinbiochem.2014.05.065","article-title":"Pharmacogenetics of chronic pain management","volume":"47","author":"Kapur","year":"2014","journal-title":"Clin Biochem"},{"issue":"6","key":"10.1016\/j.bpa.2020.07.004_bib43","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/papr.12232","article-title":"Association between human pain-related genotypes and variability in opioid analgesia: an updated review","volume":"15","author":"Nielsen","year":"2015","journal-title":"Pain Pract"},{"issue":"10","key":"10.1016\/j.bpa.2020.07.004_bib44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"\u03ba-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci"},{"issue":"1\u20133","key":"10.1016\/j.bpa.2020.07.004_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2012.06.023","article-title":"Case-control association analysis of polymorphisms in the \u03b4-opioid receptor, OPRD1, with cocaine and opioid addicted populations","volume":"127","author":"Crist","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bpa.2020.07.004_bib46","unstructured":"CPIC\u00ae guideline for codeine and CYP2D6 \u2013 CPIC."},{"issue":"9","key":"10.1016\/j.bpa.2020.07.004_bib47","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/phar.1986","article-title":"Review of opioid pharmacogenetics and considerations for pain management","volume":"37","author":"Owusu Obeng","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bpa.2020.07.004_bib48","unstructured":"FDA warned about codeine Use in Certain children after tonsillectomy and\/or adenoidectomy may lead to Death, MediMoon."},{"issue":"5","key":"10.1016\/j.bpa.2020.07.004_bib49","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.1542\/peds.2011-2538","article-title":"More codeine fatalities after tonsillectomy in North American children","volume":"129","author":"Kelly","year":"2012","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.bpa.2020.07.004_bib50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMc0904266","article-title":"Codeine, ultrarapid-metabolism genotype, and postoperative death","volume":"361","author":"Ciszkowski","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.bpa.2020.07.004_bib51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1460-9592.2006.02182.x","article-title":"Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer","volume":"17","author":"Voronov","year":"2007","journal-title":"Paediatr Anaesth"},{"issue":"1\u20133","key":"10.1016\/j.bpa.2020.07.004_bib52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2009.09.004","article-title":"Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery","volume":"147","author":"Fukuda","year":"2009","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.bpa.2020.07.004_bib53","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2217\/14622416.9.11.1605","article-title":"Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype","volume":"9","author":"Hayashida","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib54","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/bja\/aep192","article-title":"Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study","volume":"103","author":"Ginosar","year":"2009","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.004_bib55","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1213\/ANE.0b013e318273f2c7","article-title":"The effect of OPRM1 and COMT genotypes on the analgesic response to intravenous fentanyl labor analgesia","volume":"116","author":"Landau","year":"2013","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib56","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2133\/dmpk.DMPK-11-RG-134","article-title":"Impact of CYP3A5 and ABCB1 gene polymorphisms on fentanyl pharmacokinetics and clinical responses in cancer patients undergoing conversion to a transdermal system","volume":"27","author":"Takashina","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib57","first-page":"E227","article-title":"The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone","volume":"16","author":"Boswell","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.bpa.2020.07.004_bib58","series-title":"Background document pediatric advisory committee meeting benefit\/risk assessment of prescription opioid antitussive products for treatment of cough in pediatric patients","author":"Fda","year":"2017"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib59","doi-asserted-by":"crossref","first-page":"e986","DOI":"10.1542\/peds.2009-1907","article-title":"Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions","volume":"126","author":"Madadi","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpa.2020.07.004_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2013.00024","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"Zanger","year":"2013","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.bpa.2020.07.004_bib61","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.bpa.2020.07.004_bib62","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/dmd.115.064352","article-title":"Differences in methadone metabolism by CYP2B6 variants","volume":"43","author":"Gadel","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.bpa.2020.07.004_bib63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40262-015-0268-0","article-title":"The pharmacogenetics of tramadol","volume":"54","author":"Lassen","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.004_bib64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-6576.2009.02104.x","article-title":"Impact of the CYP2D6 genotype on postoperative intravenous oxycodone analgesia","volume":"54","author":"Zwisler","year":"2010","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/tpj.2013.30","article-title":"Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females","volume":"14","author":"Clarke","year":"2014","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","article-title":"Malignant hyperthermia in the post-genomics era: new perspectives on an old concept","volume":"128","author":"Riazi","year":"2018","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib67","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","article-title":"Malignant hyperthermia susceptibility and related diseases","volume":"128","author":"Litman","year":"2018","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib68","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2710.2007.00829.x","article-title":"Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines","volume":"32","author":"Fukasawa","year":"2007","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"8","key":"10.1016\/j.bpa.2020.07.004_bib69","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00221-014-3968-z","article-title":"Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting","volume":"232","author":"Janicki","year":"2014","journal-title":"Exp Brain Res"},{"issue":"9","key":"10.1016\/j.bpa.2020.07.004_bib70","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s11605-018-3788-8","article-title":"Genetic factors associated with postoperative nausea and vomiting: a systematic review","volume":"22","author":"L\u00f3pez-Morales","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib71","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000542-200503000-00011","article-title":"The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?","volume":"102","author":"Candiotti","year":"2005","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib72","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1099800412449181","article-title":"The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients","volume":"15","author":"Wesmiller","year":"2013","journal-title":"Biol Res Nurs"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.004_bib73","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3349\/ymj.2015.56.5.1415","article-title":"Association of 5-HT3B receptor gene polymorphisms with the efficacy of ondansetron for postoperative nausea and vomiting","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2008.172","article-title":"Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users","volume":"85","author":"Bijl","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.bpa.2020.07.004_bib75","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s11095-017-2104-8","article-title":"CYP2D6 genetic variation and beta-blocker maintenance dose in patients with heart failure","volume":"34","author":"Luzum","year":"2017","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.bpa.2020.07.004_bib76","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clpt.2004.08.020","article-title":"Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension","volume":"76","author":"Zineh","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib77","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clpt.2005.07.004","article-title":"Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study","volume":"78","author":"Fux","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib78","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clpt.2004.07.002","article-title":"Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics","volume":"76","author":"Kirchheiner","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2710.2006.00699.x","article-title":"The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients","volume":"31","author":"Ismail","year":"2006","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"12","key":"10.1016\/j.bpa.2020.07.004_bib80","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00228-008-0525-3","article-title":"CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction","volume":"64","author":"Goryachkina","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.bpa.2020.07.004_bib81","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00228-008-0504-8","article-title":"Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate","volume":"64","author":"Seeringer","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt.668","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update","volume":"102","author":"Johnson","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.bpa.2020.07.004_bib83","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1067\/mcp.2002.129321","article-title":"Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance","volume":"72","author":"Scordo","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib84","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jcph.813","article-title":"CYP2C9 genotype-dependent warfarin pharmacokinetics: impact of CYP2C9 genotype on R- and S-warfarin and their oxidative metabolites","volume":"57","author":"Flora","year":"2017","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.bpa.2020.07.004_bib85","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1371\/journal.pmed.0020312","article-title":"A\u00a0C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk","volume":"2","author":"Reitsma","year":"2005","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.004_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2006.10.021","article-title":"Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 \u2013 rationale and perspectives","volume":"120","author":"Yin","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.bpa.2020.07.004_bib87","series-title":"Clopidogrel therapy and CYP2C19 genotype","author":"Dean","year":"2012"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib88","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.bpa.2020.07.004_bib89","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"J\u00a0Am Med Assoc"},{"issue":"24","key":"10.1016\/j.bpa.2020.07.004_bib90","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1001\/jama.2011.1880","article-title":"CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis","volume":"306","author":"Holmes","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.bpa.2020.07.004_bib91","doi-asserted-by":"crossref","first-page":"d4588","DOI":"10.1136\/bmj.d4588","article-title":"Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis","volume":"343","author":"Bauer","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.bpa.2020.07.004_bib92","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.mayocp.2015.03.016","article-title":"Evidence for clinical implementation of pharmacogenomics in cardiac drugs","volume":"90","author":"Kaufman","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.004_bib93","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/clpt.2010.279","article-title":"CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.004_bib94","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1213\/ANE.0000000000001663","article-title":"Standardized care versus precision medicine in the perioperative setting: can point-of-care testing help bridge the gap?","volume":"124","author":"Iravani","year":"2017","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.bpa.2020.07.004_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002195","article-title":"Big data: astronomical or genomical?","volume":"13","author":"Stephens","year":"2015","journal-title":"PLoS Biol"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.004_bib96","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/cpt.1049","article-title":"Pharmacogenetic information in clinical guidelines: the european perspective","volume":"103","author":"Swen","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.bpa.2020.07.004_bib97","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.xphs.2017.04.051","article-title":"Clinical implementation of pharmacogenomics for personalized precision medicine: barriers and solutions","volume":"106","author":"Klein","year":"2017","journal-title":"J\u00a0Pharm Sci"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:28:45Z","timestamp":1776425325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689620300598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1521689620300598"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2020.07.004","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenomics, concepts for the future of perioperative medicine and pain management: A review","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}